The pharmaceutical industry exports in the Netherlands observed a notable growth over the past decade. Starting at 23.62 billion USD in 2013, they witnessed fluctuations but commenced an upward trajectory from 2018 onwards. By 2023, this value stood at 42.61 billion USD, showcasing robust growth. The year-on-year variation from 2022 to 2023 was 7.06%, with an average CAGR over the last five years bedding in at 8.45%.
Going forward, the forecasted figures indicate a positive trend. The industry is expected to reach 56.24 billion USD by 2028, translating to a forecasted 5-year CAGR of 4.38% and an overall growth rate of 23.9% from 2023 to 2028.
Future trends to watch for:
- Continued innovation in pharmaceuticals driving export growth.
- Regulatory changes and their impacts on export dynamics.
- Global health trends influencing demand for Dutch pharmaceutical products.
